Surgical resection of colorectal liver metastases. Treatment of recurrences;Resección quirúrgica de las metástasis hepáticas de carcinoma colorrectal. Tratamiento de las recidivas

Cirugia Espanola

Volumn 76, Issue 5, 2004, Pages 292-299

  Figueras Felip, Juan ^a   Torras, Jaume ^a   Martí Rague, Juan ^a   Valls, Carlos ^a   Ramos, Emilio ^a   Navarro, Matilde ^a   Rafecas, Antonio ^a   Lladó, Laura ^a   Serrano, Teresa ^a   Pares, David ^a   Fabregat, Juan ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Chemotherapy; Colorectal carcinoma; Hepatectomy; Metastases; Radiofrequency; Survival

Indexed keywords

EID: 33748743318     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(04)72380-5     Document Type: Article

References (31)

1. Benson AB, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000;18:3586-8.
2. Instituto Catalán de Oncología. Registro hospitalario de tumores. Barcelona: Ciudad Sanitaria y Universitaria
3. Landis SH, Murray T, Bolden S, Wihgo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
4. Oxley EM, Ellis H. Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg 1969;56:149-54.
5. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, et al. Five year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal metastases. Ann Surg Oncol 2001;8:347-53.
6. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984;199:502-8.
7. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-8.
8. Huges K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastastic to the liver. Optimizing the results of treatment. Surg Clin North Am 1989;69:330-59.
9. Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001;88: 980-5.
10. Fong Y, Cohen A, Fortner JG, Enker WE, Turnbull AD, Coit DG. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
11. Fortner JG, Silva JS, Cox EB, Golbey RB, Gallowitz H, MacLean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Treatment by hepatic resection. Ann Surg 1984;199:306-16.
12. Nordlinger B, Guiget M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Françaises de Chirugie. Cancer 1996;77:1254-64.
13. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 2000; 231:743-51.
14. Steele G Jr, Bleday R, Mayer RJ, Lindblad A, Petreli N, Weaver D. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver. Gastrointestinal Tumor Study Group Protocol 6584. Clin Oncol 1991;9:1105-12.
15. Solbiati L, Livraghi T, Golberg SN, Ierace T, Meloni F, Dellanoce M, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-66.
16. Hewitt PM, Dwerryhouse SJ, Zhao J, Morris DL. Multiple bilobar liver metastases. Cryotherapy for residual lesions after liver resection. J Surg Oncol 1998;67:112-6.
17. Adam R, Majno P, Castaing D, Giovernardi R, Bismuth E. Treatment of irresectable liver tumors by percutaneous cryosurgery. Br J Surg 1998;133:1011-5.
18. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as firstline treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:2938-47.
19. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-14.
20. Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kupermine M, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 2001;19:2282-92.
21. Pazdur R, Vincent M. Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5-FU + LV) in patients with advanced colorectal cancer (ACC): results of a randomized, multicenter, North American trial. Proceedings of the American Society of Clinical Oncology (ASCO) 1997 [abstract 801].
22. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kustlinger F, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10: 663-9.
23. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999;29:1099-105.
24. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, et al. Hepatic resection for metastasic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Col Surg 1999;189:291-9.
25. Valls C, López E, Guma A, Gil M, Sánchez A, Andia E, et al. Helical CT versus. CTAP in the detection of liver metastases from colorectal carcinoma. AJR 1998;170:1341-7.
26. Valls C, Andía E, Sánchez A, Gumá A, Figueras J, Torras J, Serrano T. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resecability with helical CT. Radiology 2001;218:55-60.
27. Bloed W, Van Leeuwen MS, Borel Rindes IH. Role of intraoperative ultrasound of the liver with improved hepatic imaging. Eur J Surg 2000;166:691-5.
28. Bismuth H, Castaing D, Garden OJ. Utility of operative ultrasound in the surgicalmanagement of livers tumors. Ann Surg 1986;204:600-5.
29. Machi J, Sigel B, Zaren HA, Kurohij Y, Yamashita Y. Operative ultrsonography during hepatobiliary and pancreatic surgery.World J Surg 1993;17:640-5.
30. Ruers TJ Langenhoff BS, Neeleman N. Value of postron emision tomography with (FDG18) in patients with colorectal liver metastases: A prospective review. J Clin Oncol 2002;20:388-95.
31. Kemeny N, Adak S, Gray B. Combined modality treatment for resectable mestastasic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continous infusion of chemotherapy an intergroup study. J Clin Oncol 2002;20: 1499-505.